Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes
Claus Vennegoor(Vrije Universiteit Amsterdam), Peter Kenemans, Silvia von Mensdorff‐Pouilly(Vrije Universiteit Amsterdam), W. Martin Kast(University of Southern California), René H.M. Verheijen(Radboud University Nijmegen), Rob A. Verstraeten(Vrije Universiteit Amsterdam), Hans W. Nijman(University Medical Center Groningen), Jo Hilgers, Leen N. Vernie(The Netherlands Cancer Institute), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), Jan W. Drijfhout(Leiden University)
Cited by 32
Related Papers
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
|British Journal of Cancer|2011|1.3k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
Tumor-infiltrating lymphocytes in the immunotherapy era
|Cellular and Molecular Immunology|2020|919
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851